Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2026 of 6351
-
Laser and Light-Sensitive drug shrink lung tumors in early trial
Symptom relief CompletedThis Phase I/Il studies the side effects of endobronchial ultrasound guided interstitial photodynamic therapy work in treating patients with lung cancer that has spread to nearby tissues or lymph nodes. Photodynamic therapy consists of injecting a light sensitive drug called a ph…
Phase 1/2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Experimental cell therapy targets aggressive brain tumors
Disease control OngoingThis study is being conducted to find out if the safety and tolerability of an experimental cell therapy is safe to administer to patients with a newly diagnosed glioblastoma multiforme (GBM) in combination with temozolomide (TMZ).
Phase 1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Suicide-Gene t cells aim to stop blood cancer relapse
Disease control Recruiting nowFor several decades, allogeneic hematopoietic stem cell trans-plantation (allo-HSCT) has remained an important strategy in the management of patients with high-risk hematological malignancies. The acceptance of umbilical cord blood (UCBT) and haploidentical grafts (Haplo) as viab…
Phase 1 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:15 UTC
-
New ovarian imaging could cut unneeded surgeries by 23%
Diagnosis Stopped earlyThis study is being conducted to validate if photoacoustic imaging potentially reduces benign surgeries without compromising cancer detection sensitivity. The study will also explore whether using the photoacoustic imaging/ultrasound technique has any potential with early ovarian…
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
Heart transplant drug may shield kidneys from failure
Disease control Recruiting nowHeart transplantation (TC) is the standard treatment for terminal heart failure. Chronic kidney disease (CKD) is a common complication responsible for increased mortality and morbidity. The main risk factors for progression to CKD are advanced age, pre-transplantation CKD, degrad…
Phase 2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can we better support new mothers Who've had Weight-Loss surgery?
Knowledge-focused CompletedWomen with a history of bariatric surgery may face various difficulties during pregnancy and puerperal time. Therefore it is assumed the prevalence of mental health disorders might be higher than in average women during and after pregnancy. This could possibly lead to an unsatisf…
Sponsor: Wuerzburg University Hospital • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Could a diabetes drug help detect Alzheimer's early?
Diagnosis OngoingIn this multi-center study, the investigators plan to develop a simple blood-based test for early detection of Alzheimer's disease (AD). The test is based on a single injection of Pramlintide, an amylin analogue and FDA-approved drug currently used for treatment of diabetes. The …
Early phase 1 • Sponsor: Boston University • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
Could a cancer drug shield young transplant patients from a deadly complication?
Disease control OngoingThe purpose of this study is to determine the recommended phase 2 dose of the drug Vorinostat in children, adolescents and young adults following allogeneic blood or marrow transplant (BMT) and determine whether the addition of Vorinostat to the standard graft versus host disease…
Phase 1/2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New approach tackles social stressors to help refugees with PTSD
Symptom relief CompletedINTRODUCTION Trauma-affected refugees are at high risk of developing mental health problems including post-traumatic stress disorder (PTSD) and depression. In addition to traumatic stress, refugees are furthermore subject to a range of post-migration stressors e.g. unemployment, …
Sponsor: Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Could an antibiotic help when antidepressants fail?
Symptom relief CompletedMajor depressive disorder (MDD) is a leading cause of disability worldwide. Up to 50% of patients experience treatment resistant depression (TRD), which accounts for a vast majority of disease burden. Current medications for TRD have limited efficacy and can be associated with in…
Phase 3 • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Teen artery stiffness study tests carnitine supplement for heart health
Disease control OngoingHardening of the blood vessels, called arterial stiffness, is a risk factor for future heart disease and its causes are unclear. The proposed study will 1) randomly assign adolescents at high risk of stiffening blood vessels to take a protein supplement called carnitine and study…
Phase 2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Kicking HIV: soccer program boosts testing and care for teens
Disease control Completed"SKILLZ," is a mixed methods evaluation of the Grassroots Soccer (GRS) SKILLZ Package based in Lusaka, Zambia. The package is made up of three football-based programs: (1) SKILLZ-Girl - implemented in schools as part of a 10-week program culminating in a tournament event; (2) SKI…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could a vitamin cocktail fix energy problems in autism?
Disease control CompletedThe objective of this study is to evaluate the metabolic effects of a comprehensive wide-spectrum supplement for children with ASD to determine whether it physiologically targets mitochondrial pathways known to be abnormal in children with ASD.The intervention is a commonly used …
Phase 2 • Sponsor: Rossignol Medical Center • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can surgery for a bowel disorder also lift depression and anxiety?
Symptom relief CompletedBackground: Obstructed Defecation Synsdrome (ODS) causes people to strain and sometimes need help to go to the toilet. They think about going to the toilet a lot, which makes their lives worse. People with Obstructed Defecation Synsdrome (ODS) are more likely to be anxious and de…
Sponsor: Evangelisches Klinikum Köln Weyertal gGmbH • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
At-home gadget shows promise for chronic nerve pain relief
Symptom relief CompletedRandomized controlled trial to assess the effectiveness and patient perception of the benefit of the Sana Pain Reliever in individuals with chronic neuropathic pain.The study is fully remote with four study visits taking place over teleconferencing and the study devices mailed to…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Umbilical cord wrap may help men recover faster after prostate cancer surgery
Symptom relief OngoingThis study aims at evaluating if placement of CLARIX® CORD 1K during robotic prostatectomy decreases the time to achieve complete erectile and urinary function after the surgery. As part of the study, the patient will be asked to answer various questions after the surgery regardi…
Phase 2/3 • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Drug duo targets tough tumors in early trial
Disease control OngoingThis phase II trial studies how well olaparib and ceralasertib (AZD6738) work in treating patients with IDH mutant cholangiocarcinoma or solid tumors. Cancer is caused by changes (mutations) to genes that control the way cells function. Laboratory studies have shown that olaparib…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug combo aims to boost immune system against Hard-to-Treat cancers
Disease control CompletedThe purpose of this study is to assess the safety and tolerability of BGB-A445 alone and in combination with tislelizumab in participants with advanced solid tumors; and to determine the maximum tolerated dose(s) (MTD) or maximum administered dose(s) (MAD) and recommended Phase 2…
Phase 1 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Pee power: urine test could spot kidney cancer without needles
Diagnosis Recruiting nowClear cell renal cell carcinoma is diagnosed by imaging, sometimes associated with biopsy. This diagnosis is expensive, invasive and sometimes late. The development of a simple biological test for diagnosis is essential. Exosomes are 30 to 150 nm membrane vesicles secreted into t…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New targeted pill shows promise for japanese blood cancer patients
Disease control CompletedThis is a Phase 1/2 study of zanubrutinib in Japanese participants with mature B-cell malignancies. This study intends to assess the use of zanubrutinib as an investigational agent to develop new treatment options for Japanese participants with B-cell malignancies. No formal hyp…
Phase 1/2 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC